Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MYNFLU-001 by Mynvax for Seasonal Influenza: Likelihood of Approval
MYNFLU-001 is under clinical development by Mynvax and currently in Phase I for Seasonal Influenza. According to GlobalData, Phase I...